{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:31:07Z","timestamp":1761363067001,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002920","name":"University Grants Committee Research Grants Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jcv.2022.105351","type":"journal-article","created":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T09:39:00Z","timestamp":1670751540000},"page":"105351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Association of human cytomegalovirus in urine with end-organ diseases in stage 2\/3 HIV-1-infected individuals"],"prefix":"10.1016","volume":"158","author":[{"given":"Fang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsz Yan","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8989-0537","authenticated-orcid":false,"given":"Allen Ka Loon","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jcv.2022.105351_bib0001","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood-2005-12-026682","article-title":"Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells","volume":"108","author":"Cheung","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jcv.2022.105351_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003366","article-title":"Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells","volume":"9","author":"Rossetto","year":"2013","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.jcv.2022.105351_bib0003","doi-asserted-by":"crossref","first-page":"e00013","DOI":"10.1128\/mBio.00013-18","article-title":"Defining the transcriptional landscape during cytomegalovirus latency with single-cell RNA sequencing","volume":"9","author":"Shnayder","year":"2018","journal-title":"MBio"},{"issue":"49","key":"10.1016\/j.jcv.2022.105351_bib0004","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1710522114","article-title":"Transcriptome-wide characterization of human cytomegalovirus in natural infection and experimental latency","volume":"114","author":"Cheng","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"5","key":"10.1016\/j.jcv.2022.105351_bib0005","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/bloodadvances.2016000638","article-title":"Latent human cytomegalovirus enhances HIV-1 infection in CD34+ progenitor cells","volume":"1","author":"Cheung","year":"2017","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.jcv.2022.105351_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247264","article-title":"Human cytomegalovirus infection among treatment-naive HIV-1 infected patients in Ethiopia","volume":"16","author":"Kiros","year":"2021","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.jcv.2022.105351_bib0007","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/QAI.0000000000000410","article-title":"Diagnostic utility of quantitative plasma cytomegalovirus DNA PCR for cytomegalovirus end-organ diseases in patients with HIV-1 infection","volume":"68","author":"Mizushima","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"10.1016\/j.jcv.2022.105351_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117466","article-title":"Distribution and determinants of cytomegalovirus induced end organ disease\/s among people living with HIV\/AIDS in a poor resource setting: observation from India","volume":"10","author":"Chakraborty","year":"2015","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.jcv.2022.105351_bib0009","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/375843","article-title":"Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS clinical trials group protocol 360)","volume":"37","author":"Erice","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jcv.2022.105351_bib0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJM199707103370207","article-title":"Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome","volume":"337","author":"Jacobson","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jcv.2022.105351_bib0011","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/166.6.1223","article-title":"Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group","volume":"166","author":"Gallant","year":"1992","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.jcv.2022.105351_bib0012","first-page":"1069","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"5","author":"Pertel","year":"1988","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"10.1016\/j.jcv.2022.105351_bib0013","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/infdis\/jiu417","article-title":"Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients","volume":"211","author":"Lichtner","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jcv.2022.105351_bib0014","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.21037\/apm-20-1352","article-title":"Cytomegalovirus (CMV) infection in HIV\/AIDS patients and diagnostic values of CMV-DNA detection across different sample types","volume":"9","author":"Zhao","year":"2020","journal-title":"Ann. Palliat. Med."},{"issue":"2","key":"10.1016\/j.jcv.2022.105351_bib0015","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/clinids\/14.2.608-a","article-title":"Cytomegalovirus infection in patients with AIDS","volume":"14","author":"Drew","year":"1992","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jcv.2022.105351_bib0016","first-page":"540","article-title":"Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group","volume":"2","author":"Lang","year":"1988","journal-title":"J. Acquir. Immune Defic. Syndr"},{"issue":"2","key":"10.1016\/j.jcv.2022.105351_bib0017","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1537-2995.1988.28288179029.x","article-title":"Prevalence of cytomegalovirus antibody in hemophiliacs and homosexuals infected with human immunodeficiency virus type 1","volume":"28","author":"Jackson","year":"1988","journal-title":"Transfusion (Paris)"},{"issue":"1","key":"10.1016\/j.jcv.2022.105351_bib0018","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/infdis\/173.1.77","article-title":"Factors associated with cytomegalovirus infection among human immunodeficiency virus type 1-seronegative and -seropositive women from an urban minority community","volume":"173","author":"Clarke","year":"1996","journal-title":"J. Infect. Dis."},{"issue":"8654","key":"10.1016\/j.jcv.2022.105351_bib0019","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(89)90312-7","article-title":"Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection","volume":"2","author":"Webster","year":"1989","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jcv.2022.105351_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199907083410203","article-title":"Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group","volume":"341","author":"Kovacs","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.jcv.2022.105351_bib0021","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1128\/JVI.73.8.7027-7030.1999","article-title":"Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS","volume":"73","author":"Spector","year":"1999","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.jcv.2022.105351_bib0022","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI1101","article-title":"Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients","volume":"101","author":"Spector","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.jcv.2022.105351_bib0023","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/infdis\/170.5.1271","article-title":"Detection of cytomegalovirus DNA in serum correlates with clinical cytomegalovirus retinitis in AIDS","volume":"170","author":"Hansen","year":"1994","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jcv.2022.105351_bib0024","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/infdis\/175.1.179","article-title":"Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients","volume":"175","author":"Rasmussen","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jcv.2022.105351_bib0025","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00042560-199604150-00006","article-title":"Seroepidemiology of cytomegalovirus in patients with advanced HIV disease: influence on disease expression and survival","volume":"11","author":"Shepp","year":"1996","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"issue":"1","key":"10.1016\/j.jcv.2022.105351_bib0026","first-page":"S37","article-title":"Lessons from the natural history of cytomegalovirus","volume":"10","author":"Bowen","year":"1996","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.jcv.2022.105351_bib0027","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/infdis\/157.3.508","article-title":"Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus","volume":"157","author":"Skolnik","year":"1988","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jcv.2022.105351_bib0028","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1590\/S1413-86702007000100039","article-title":"Multiorgan involvement due to cytomegalovirus infection in AIDS","volume":"11","author":"Majumder","year":"2007","journal-title":"Braz. J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.jcv.2022.105351_bib0029","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/00002030-199908200-00009","article-title":"Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group","volume":"13","author":"Casado","year":"1999","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.jcv.2022.105351_bib0030","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00002030-200005260-00017","article-title":"Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy","volume":"14","author":"Salmon-Ceron","year":"2000","journal-title":"AIDS"},{"issue":"9427","key":"10.1016\/j.jcv.2022.105351_bib0031","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(04)16500-8","article-title":"Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy","volume":"363","author":"Deayton","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jcv.2022.105351_bib0032","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.qai.0000155204.96973.c3","article-title":"Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies","volume":"38","author":"Wohl","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jcv.2022.105351_bib0033","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coviro.2014.08.001","article-title":"Human cytomegalovirus intrahost evolution-a new avenue for understanding and controlling herpesvirus infections","volume":"8","author":"Renzette","year":"2014","journal-title":"Curr. Opin. Virol."},{"issue":"2","key":"10.1016\/j.jcv.2022.105351_bib0034","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/421496","article-title":"Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients","volume":"39","author":"Coaquette","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jcv.2022.105351_bib0035","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/infdis\/150.6.952","article-title":"Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization","volume":"150","author":"Drew","year":"1984","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jcv.2022.105351_bib0036","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1038\/s41598-022-11727-2","article-title":"A comparative analysis depicting the disease characteristics and phylogenetic signature of human cytomegalovirus infection in Human Immunodeficiency Virus 1 seropositive patients with end-organ retinitis and gastro-enteric diseases","volume":"12","author":"Chatterjee","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jcv.2022.105351_bib0037","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2174\/187152611797636703","article-title":"Overview of the diagnosis of cytomegalovirus infection","volume":"11","author":"Ross","year":"2011","journal-title":"Infect. Disord. Drug Targets"},{"issue":"10","key":"10.1016\/j.jcv.2022.105351_bib0038","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1469-0691.2007.01781.x","article-title":"Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system","volume":"13","author":"Steininger","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.jcv.2022.105351_bib0039","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/13550289809113490","article-title":"Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European union concerted action on virus meningitis and encephalitis","volume":"4","author":"Cinque","year":"1998","journal-title":"J. Neurovirol."},{"issue":"9","key":"10.1016\/j.jcv.2022.105351_bib0040","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00007435-199810000-00006","article-title":"Incidence and sexual risk factors of cytomegalovirus seroconversion in HIV-infected subjects. The SEROCO Study Group","volume":"25","author":"Robain","year":"1998","journal-title":"Sex Transm. Dis."},{"issue":"4","key":"10.1016\/j.jcv.2022.105351_bib0041","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jmv.1890240405","article-title":"Seroepidemiologic studies on the acquisition of antibodies to cytomegalovirus, herpes simplex virus, and human immunodeficiency virus among general hospital patients and those attending a clinic for sexually transmitted diseases","volume":"24","author":"Berry","year":"1988","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.jcv.2022.105351_bib0042","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1310\/hct1003-143","article-title":"Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030","volume":"10","author":"Wohl","year":"2009","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.jcv.2022.105351_bib0043","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2334-14-245","article-title":"Urine real-time polymerase chain reaction detection for children virus pneumonia with acute human cytomegalovirus infection","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"5","key":"10.1016\/j.jcv.2022.105351_bib0044","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.jcv.2022.105351_bib0045","doi-asserted-by":"crossref","first-page":"e8886","DOI":"10.1371\/journal.pone.0008886","article-title":"Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease","volume":"5","author":"Naeger","year":"2010","journal-title":"PLoS ONE"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653222002839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653222002839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:16:48Z","timestamp":1761362208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653222002839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":45,"alternative-id":["S1386653222002839"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2022.105351","relation":{},"ISSN":["1386-6532"],"issn-type":[{"type":"print","value":"1386-6532"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of human cytomegalovirus in urine with end-organ diseases in stage 2\/3 HIV-1-infected individuals","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2022.105351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105351"}}